Indeed, the role of CD4+ T cells in the tumor microenvironment is of growing interest as these cells have been shown to be required for efficacious anti-tumor immunity and can target tumor cells in various ways (reviewed by Borst et. The gene discussed is CD4; the disease is neoplasm.